Second, the designed stapled peptide, SAH-mAH2-5, exhibited profound anti-pancreatic cancer effects, especially in Notch1-hyperactivated pancreatic cancer, in multiple preclinical models. The gene discussed is NOTCH1; the disease is familial pancreatic carcinoma.